Articles

  A prospective evaluation study published in the Journal of Clinical Microbiology evaluated our ResistancePlus® MG assay against 1089 symptomatic and asymptomatic male and female urine and anogenital swab samples. Key Findings 6%...

A recent article posted in Clinical Lab Products (CLP) by Professor Sepehr Tabrizi, Royal Women’s Hospital, Melbourne, describes our current understanding of Mycoplasma genitalium, the rise of treatment failure due...

Announcing the first publication for our ResistancePlus® MG assay, published in PLOS ONE in collaboration with Sepehr Tabrizi, PhD at the Royal Women’s Hospital in Melbourne, Australia. “The SpeeDx assay provides...

Austrade’s Success Stories article highlights our focus in tackling the growing threat of antimicrobial resistance using precision medicine. SpeeDx develops clinical diagnostic tests which are faster and more accurate in...